SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-031953
Filing Date
2017-05-12
Accepted
2017-05-12 16:26:10
Documents
1
Period of Report
2017-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4090
  Complete submission text file 0001209191-17-031953.txt   5455
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Issuer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTINE DESIGN LAB 7442 NORTH MARCER WAY MERCER ISLAND WA 98040
Business Address
MCDADE MARK (Reporting) CIK: 0001242126 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36070 | Film No.: 17839020